SHLX 34.18 Shell Midstream Partners L.P. $SHLX Hit a 52

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
SHLX 34.18 Shell Midstream Partners L.P. $SHLX Hit a 52 week high of 35.23 Closing the day 11/07/14 at 34.18 +1.58 +4.85% With a day low of 32.50 and a total volume of 472,303.

SHLX Recent Posts: http://investorshangout.com/Shell-Midstream-P...HLX-90647/

SHLX Shell Midstream Partners L.P. Recent Headline News

IPO Calendar: Market Activity Reignites With 11 IPOs
at Investor's Business Daily - Mon Nov 03, 2:07PM CST
At least 11 IPOs are scheduled to begin trading this week, looking to raise about $1.7 billion and signaling a pickup after three weeks of sluggishness. After five or fewer initial public offerings in each of the past three weeks, the IPO calendar...
IPO: 23.52 (+0.12), JAGX: (), AR: 55.06 (+2.26), SHLX: 34.18 (+1.58), FRPT: 19.11 (+19.11), UPLD: 10.81 (+1.06), INCR: 20.49 (+20.49), NVRO: 25.30 (+0.11), CHRS: 15.10 (+2.49), TBK: 12.75 (+12.75), SKYS: (), YDLE: 13.67 (+0.58), JYNT: (), AM: 28.07 (-0.18), HUBS: 36.70 (+0.41)

Shell Midstream Partners MLP Jumps In Debut
at Investor's Business Daily - Wed Oct 29, 11:32AM CDT
Shell Midstream Partners (SHLX) shares soared on its first day of trading on the New York Stock Exchange. The master limited partnership and spin-off from Royal Dutch Shell (RDSA) priced at 23 per share late Tuesday, topping its expected range of...
SHLX: 34.18 (+1.58)

Shell Midstream Partners (SHLX) Stock Pops in First Trading Day After IPO
at The Street - Wed Oct 29, 10:46AM CDT
Shares of Shell Midstream Partners (SHLX) surged in morning trading Wednesday, the company's first trading day after its IPO.
SHLX: 34.18 (+1.58), RDS.A: 71.00 (+1.54)

U.S. Pipeline Operator Shell Midstream Comes on Stream on the NYSE
at The Street - Wed Oct 29, 8:35AM CDT
Royal Dutch Shell remains the majority shareholder.
SHLX: 34.18 (+1.58), RDS.A: 71.00 (+1.54)

Shell Midstream Partners, L.P. Announces Pricing of Initial Public Offering
GlobeNewswire - Tue Oct 28, 4:28PM CDT
Shell Midstream Partners, L.P., a limited partnership formed by Royal Dutch Shell, announced the pricing of its initial public offering of 40,000,000 common units representing limited partner interests at $23.00 per common unit. The underwriters of the offering have a 30-day option to purchase up to an additional 6,000,000 common units from Shell Midstream Partners. The common units will begin trading on the New York Stock Exchange on October 29, 2014 under the ticker symbol "SHLX." The offering is expected to close on or about November 3, 2014, subject to customary closing conditions.
SHLX: 34.18 (+1.58)

Royal Dutch Shell Sets IPO Price Range for U.S. Pipeline Operator
at The Street - Tue Oct 21, 9:02AM CDT
The Anglo-Dutch group expects proceeds of at least $711 million from the sale of almost a third of Shell Midstream Partners.
SHLX: 34.18 (+1.58), RDS.A: 71.00 (+1.54), CELP: 21.25 (-0.18), PBFX: 25.19 (-0.29)

Shell Midstream sets IPO
at Investor's Business Daily - Mon Oct 20, 5:57PM CDT
Royal Dutch Shell (RDSA) announced the terms for its IPO of Shell Midstream Partners (SHLX). The new company plans to raise about $750 mil by offering 37.5 mil shares, with a 19-21 expected price range. The midpoint of 20 would give the new company a...
SHLX: 34.18 (+1.58)

Video: Shell's Midstream Business Sets IPO Terms
at Investor's Business Daily - Mon Oct 20, 11:24AM CDT
Oil majors continue to spin off volatile midstream operations, and on Monday Royal Dutch Shell (RDSA) set the terms for its midstream initial public offering as oil prices continue to fall. Shell Midstream Partners (SHLX) plans to raise about $750...
PSX: 74.70 (-0.72), SHLX: 34.18 (+1.58), COP: 72.16 (+0.84), CVX: 118.80 (+0.27)

Shell Midstream Partners (SHLX) Stock Research Links

SHLX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Explore Rosanne Cash's Journey in a Unique Exhibition

Updated Category News Views 179

Rosanne Cash Exhibition at the Country Music Hall of Fame The Country Music Hall of Fame and Museum is set to showcase a remarkable exhibition centered on the influential career of Rosanne Cash. This exhibition, titled "Rosanne Cash: Time Is a Mirror," will delve into her extensive journey as an artist, encompassing her evolution as a songwriter and storyteller....

Continue Reading
Transforming Moving Services in Boston: A Commitment to Excellence

Updated Category News Views 91

Transforming Moving Services for Boston Residents Boston's vibrant atmosphere has led to an increased demand for efficient and modern moving solutions. Safe Responsible Movers is dedicated to meeting these needs, offering top-notch services tailored to the specific challenges that both residents and businesses experience. With a solid reputation established over the...

Continue Reading
Endeavour Mining Completes Share Buyback with Significant Volume

Updated Category News Views 196

Endeavour Mining's Recent Share Buyback Announcement Endeavour Mining plc has made a notable step in its commitment to returning value to shareholders through the recent purchase of its ordinary shares. The company has acquired shares from Stifel Nicolaus Europe Limited, marking a significant move in its ongoing buyback program. Aggregated Information on the Share...

Continue Reading
Kristi Vassak Steps Up as COO of Lenox Advisors to Lead Growth

Updated Category News Views 288

Kristi Vassak Takes on Key Role at Lenox Advisors Lenox Advisors, an esteemed wealth management and insurance advisory firm, has appointed Kristi Vassak as Chief Operating Officer. This significant promotion reflects not only her extensive tenure but also her transformative leadership within the company. As a long-term employee who joined the firm in 2005, Vassak has...

Continue Reading
Werewolf Therapeutics Showcases Innovations at Kidney Cancer Summit

Updated Category News Views 134

Werewolf Therapeutics Engages at Kidney Cancer Research Summit WATERTOWN, Mass. — Werewolf Therapeutics, Inc. (the "Company" or "Werewolf") (Nasdaq: HOWL), a forward-thinking biopharmaceutical company, is making strides in its mission to revolutionize cancer treatment through conditionally activated therapeutics. This approach aims to empower the body’s immune system...

Continue Reading